Settlement of Several Canadian Class Actions Relating to the Prescription Drugs OxyContin and OxyNEO, Including Cases Filed by Siskinds LLP and Siskinds, Desmeules

A settlement has now been approved in the Canadian Oxycontin Class Actions.
File your claim on or before February 27, 2024, at

A Canada-wide settlement has been approved to settle several Canadian class actions relating to the prescription drugs OxyContin and OxyNEO, including cases filed by Siskinds LLP and Siskinds, Desmeules. The Settlement will compensate eligible class members for various injuries that they suffered due to addictions that they developed from using these prescription Oxy drugs.
The Canadian OxyContin Class Action Settlement is now open to claims. Anyone who was prescribed and ingested OxyContin and/or OxyNEO in Canada between January 1, 1996, and February 28, 2017, is eligible to claim under the settlement. Estates of deceased Canadian Oxy users are also eligible to file claims, as are spouses, children, and certain other family members. Class members have until February 27th, 2024, to file a claim.
For more information, please read the Notice of Settlement Approval, or visit the Canadian OxyContin Class Action Settlement website at: or contact the claims administrator at 1-888-663-7185 or by email at
If you used prescription OxyContin or OxyNEO in Canada at any time between 1996 and 2017, and you suffered from opioid addiction, we encourage you to email Siskinds LLP at, call us toll-free at 1-800-461-6166, or complete the form on this page.
OxyContin®/OxyNEO® User Claim Form
Family Member Claim Form
Visit OxyContin® and OxyNEO® Class Action Settlement for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *